1. Service des Maladies du Sang, Hôpital Claude Huriez, Lille, France;
2. Department of Clinical Therapeutics, National and Kapodistrian University of Athens School of Medicine, Athens, Greece;
3. Mayo Clinic, Rochester, MN;
4. Frankston Hospital and Monash University, Frankston, Australia;
5. Cross Cancer Institute, Edmonton, Canada;
6. Seragnoli Institute of Hematology, Bologna University School of Medicine, Bologna, Italy;
7. Department of Hematology and Developmental Therapeutics, Hematology/Oncology and Stem Cells Transplantation Unit, National Cancer Institute, Fondazione “Pascale,” Naples, Italy;
8. Department of Hematology, University of Tuebingen, Tuebingen, Germany;
9. Wilhelminenspital, Center for Oncology, Vienna, Austria;
10. Southern Alberta Cancer Research Institute, University of Calgary, Calgary, Canada;
11. Centre Hospitalier de la Côte Basque, Bayonne, France;
12. Department of Hematology, University Hospital, La Roche Sur Yon, France;
13. University Hospital Leuven, Leuven, Belgium;
14. Barts Health National Health Service Trust, London, United Kingdom;
15. Hospitais da Universidade de Coimbra, Coimbra, Portugal;
16. Chonnam National University Hwasun Hospital, Jeollanamdo, South Korea;
17. Princess Margaret Hospital, Toronto, Canada;
18. Institut Català d’Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Badalona, Spain;
19. Hospital Dr. Peset, Valencia, Spain;
20. Queen Elizabeth II Health Sciences Centre, Halifax, Canada;
21. Kantonsspital Winterthur, Winterthur, Switzerland;
22. Peking University People’s Hospital, Beijing, China;
23. Dana-Farber Cancer Institute, Boston, MA;
24. Department of Hematology, University of Nantes, Nantes, France;
25. Institut Universitaire du Cancer, Toulouse-Oncopole, France;
26. Centre Hospitalier Régional Universitaire de Nancy, Université de Lorraine, Nancy, France;
27. Hopital Saint Louis, Paris, France;
28. Blood Disease Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Tianjin, China;
29. Centre Hospitalier Universitaire Purpan/Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France;
30. Hôpital Saint-Antoine, Paris, France;
31. Unite de Genomique du Myelome, Centre Hospitalier Universitaire Rangueil, Toulouse, France;
32. Hôpital de la Milétrie, Centre Hospitalier Universitaire INSERM, Poitiers, France;
33. Celgene Corporation, Summit, NJ;
34. Centre Hospitalier Universitaire Hôpital Bretonneau, Tours Cedex, France; and
35. Bordeaux Hospital University Center (Centre Hospitalier Universitaire), Bordeaux, France